dual MEK/PI3K pathway inhibitors (University of Michigan)

N/A

Report date: 2025/03/19 11:38:46
NME

Base Information

Drug Namedual MEK/PI3K pathway inhibitors (University of Michigan)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDual specificity mitogen-activated protein kinase kinase inhibitorsPI3-kinase class I inhibitors
TargetsDual specificity mitogen-activated protein kinase kinasePI3-kinase class I
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Michigan
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Michigan
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A